Prenatal & Maternal Care

Labassure’s Prenatal & Maternal Care diagnostics are designed to support expectant parents and clinicians with timely, accurate, and clinically actionable insights throughout pregnancy. From preconception genetic screening to advanced prenatal testing and high-risk pregnancy monitoring, our comprehensive portfolio enables early identification of genetic, chromosomal, and maternal health risks—empowering personalized, proactive care.
‍

We ensure comprehensive, precise, and compassionate care, supporting the healthiest possible outcomes throughout the pregnancy journey.

‍

Find the Right Test for Your Needs

Non-Invasive Prenatal Screening (NIPS)

High sensitivity screening for common genetic abnormalities using Next Generation Sequencing (NGS) technology

Carrier Screening

Determines parental carrier status for inherited disorders, identifying hidden genetic risks to guide reproductive planning, informed decision-making, and healthier family outcomes

Prenatal Screening

Early evaluation of fetal chromosomal abnormality risks such as Down, Edwards, and Patau syndromes—supporting counseling, targeted monitoring, and informed pregnancy management

Prenatal Diagnosis

Confirmed diagnosis to rule out the suspected genetic abnormalities in the fetus. Performed on prenatal sample obtained through CVS/Amniocentesis procedure.

Pre-eclampsia Risk Assessment

Early assessment markers to help identify the risks of eclampsia during delivery enabling decisions regarding preventive steps and closer monitoring decisions.

Comprehensive Prenatal & Maternal Care Diagnostics

We begin with carrier screening, which identifies whether one or both parentscarry gene variants for inherited disorders such as thalassemia, cysticfibrosis, and spinal muscular atrophy. This pre-pregnancy or early pregnancy test is vital for assessing the risk of passing on genetic conditions

Our Non-Invasive Prenatal Testing (NIPT) provides high-accuracy screening for chromosomal abnormalities like Down syndrome, Trisomy 18, and 13 using only a maternal blood sample.

We offer biochemical prenatal screenings (Double, Triple, and Quadruple Marker tests) to assess fetal risk for chromosomal anomalies and neural tube defects during the first and second trimesters.

Labassure provides invasive diagnostic testing, including amniocentesis and CVS, followed by karyotyping, FISH, chromosomal microarray (CMA), and mutation analysis for high-risk pregnancies.

For maternal health, we offer Pre-eclampsia Risk Assessment using the sFlt-1/PlGF ratio to predict pre-eclampsia risk, ensuring timely intervention and better outcomes for mother and baby.

Prenatal & Maternal Care

Find the Right Test for Your Needs

Comprehensive Prenatal & Maternal Care Diagnostics

Corporate

Test & Services